Development and Validation of Safety of a New Antimicrobial Agent Therapy to early healing for Individual Periodontal Disease

Development and Validation of Safety of a New Antimicrobial Agent Therapy to early healing for Individual Periodontal Disease - Establishment of Individualized Treatment of Periodontal Disease with Systemically Administrated Antimicrobial Agent

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000012033

Enrollment

Registered

2013-11-01

Start date

2013-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periodontitis

Interventions

Full-Mouth Scaling and Root Planing in Conjunction with Systemically Administrated Azithromycin. Full-Mouth Scaling and Root Planing in Conjunction with Systemically Administrated Sitafloxacin.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients having more than 20 teeth and having multiple site of probing pocket depth more than 4 mm 2) Patients who can give informed consent themselves in writing

Exclusion criteria

Exclusion criteria: 1) Patients with any systemic illness known to affect the outcomes of periodontal treatment 2) Pregnancy and/or lactation 3) Smoker 4) Other(Doctors dicision)

Design outcomes

Primary

Measure	Time frame
The Primary Outcome of this Study is to Evaluate the Efficacy for New Antimicrobial Agent Therapy for Periodontal Disease Patient.	—

Secondary

Measure	Time frame
The Secondary Outcome of this Study is to Evaluate the Safety for New Antimicrobial Agent Therapy for Periodontal Disease Patient.	—

Countries

Japan

Contacts

Public ContactTakatoshi Nagano

Tsurumi University School of Dental Medicin Department of Periodontology

nagano-takatoshi@tsurumi-u.ac.jp045-580-8434

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026